Global Oral Cancer Treatment Market – Industry Trends and Forecast to 2030

Global Oral Cancer Treatment Market, By Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, and Oral Cavity Lymphomas), Therapy Type (Chemotherapy, Radiation Therapy, and Biological Therapy), Treatment (Medication and Surgery), Route of Administration (Oral, Injectable, and Others), End Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) – Industry Trends and Forecast to 2030.

Oral Cancer Treatment Market Analysis and Size

Oral cancer is a serious problem worldwide. According to the Oral Cancer Foundation, about 53,000 new oral cancer cases are diagnosed each year, and more than 9,750 people suffer from this disease in the U.S. This prevalence demands a higher need for treatment. Dental technology developments are expected to offer companies with lucrative growth prospects.

Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oral Cancer Treatment Market Scope and Segmentation

Market Definition

Oral cancer is a type wherein the malignant tumor develops in the tissues in the mouth and around the throat. It is also known as mouth cancer. The common symptoms associated with it are white patches and ulcers. Oral cancers are either benign or malignant. Furthermore, surgical removal of benign tumors is possible with regard to its treatment.

Global Oral Cancer Treatment Market Dynamics

Drivers

• Increasing Prevalence of Oral Cancer

The increasing prevalence of oral cancer is increasing the market growth demand. As per the American Cancer Society, oral and oropharyngeal cancer prevalence has been growing in recent years. This increasing elderly population has higher chances of oral cancer, which grows the market. In 2021, around 54,010 people in the U.S. were diagnosed with oral cavity or oropharyngeal cancer, and around 10,850 died for the same.  As per the National Cancer Institute, in the U.S. in 2021, there were approximately 53,260 new oral and oropharyngeal cancer cases and an estimated 10,750 deaths from these cancers. This increasing prevalence demands the high treatment processes of oral cancer, which further leads to market growth. Thus, this factor leads to the growth of the market.

Opportunities

• Growing Elderly Population

Increasing rate of elderly population leads to market growth. For instance, a lack of poor oral health and a switch from complex to simple carbohydrates let the elderly at risk for developing root caries. Over 50% of people aged 75 years and above have at least one tooth affected by root caries which further causes little damage can weaken the entire tooth leading to the severe infection. Thus, this factor boosts market growth.  

• Increasing Healthcare Expenditure

Dental technology developments are expected to provide companies with huge growth prospects. For instance, Pearl raised US$ 11 million in May 2019 to use AI to measure dental scans. As per the company, it will ease the tedious, repetitive operations, boost profits across dentistry, and—most notably improve the level of care. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

• High Cost of Oral Cancer Treatment

The huge cost of treatment and diagnostic procedures related to oral cancer hinders the market. Numerous procedures are costly and cannot be afforded by underdeveloped and developing countries. Thus, this factor impedes market growth.  

• Side Effects of Oral Cancer Treatment

There are huge side effects associated with oral cancer treatment. There are several severe side effects that may arise if the dosage is high such as hair loss, mouth sores, loss of appetite or weight loss, nausea and vomiting which restricts the patient from adopting the treatment for a long time. Thus, this factor impedes the market growth.

This oral cancer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oral cancer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, ZimVie Inc. launched TSX Implant in the U.S., the latest innovation in the company's surgical, restorative, and digital dentistry solutions platform. TSX Implants are designed for instant extraction and loading protocols, placement predictability, and primary stability in soft and dense bone.

Global Oral Cancer Treatment Market Scope

The oral cancer treatment market is segmented on the basis of type, therapy type, treatment, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Oral Squamous Cell Carcinoma
• Oral Verrucous Carcinoma
•  Mucoepidermoid Carcinoma
• Oral Cavity Lymphomas

Therapy Type

• Chemotherapy
• Radiation Therapy
• Biological Therapy

Treatment

• Medication
• Cisplatin
• Docetaxel
• Methotrexate
• Bleomycin Sulfate
• Pembrolizumab
• Surgery
• Laryngectomy
• Glossectomy
• Others

Route of Administration

• Oral
• Injectable
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
•  Others

Oral Cancer Treatment Market Regional Analysis/Insights

The oral cancer treatment market is analyzed and market size insights and trends are provided by type, therapy type, treatment, route of administration, end users, and distribution channel as referenced above.

The countries covered in the oral cancer treatment market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period because of the increasing expenditure to develop healthcare infrastructure and growing tobacco consumption. The market growth is also enhanced by the launch of products in the region.

North America dominates the market in the forecast to the rising affordability of drugs and the surge in the cases of oral cancer. Furthermore, growing awareness among the people in this region to cure dental caries and technological developments because of the presence of major market players lead to market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The oral cancer treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oral cancer treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oral cancer treatment market. The data is available for historic period 2011-2021.

Competitive Landscape and Oral Cancer Treatment Market Share Analysis

The oral cancer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oral cancer treatment market.

Some of the major players operating in the oral cancer treatment market are:

• Bayer AG (Germany)
• Aurobindo Pharma (India)
• AbbVie Inc. (U.S.)
• Novartis AG (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Bausch Health Companies Inc. (U.S.)
• Accord Healthcare (U.K.)
• Genentech, Inc (U.S.)
•  Bristol-Myers Squibb Company (U.S.)
• GSK plc (U.K.)
• Ascendis Pharma A/S (Denmark)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Lupin (India)